Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI’s Selby Expects More Drug-Related Comparative Research In 2014

Executive Summary

Research involving drugs has been limited since the Patient-Centered Outcomes Research Institute began project funding, but institute Executive Director Joe Selby expects that to change as PCORI prepares to issue funding announcements for pragmatic trials.

You may also be interested in...



PCORI Approves 45 CER Projects

The Patient-Centered Outcomes Research Institute awarded 45 grants for comparative effectiveness research in its Dec. 17 announcement, which included the first drug vs. drug clinical trial for neuropathy and studies of medication adherence.

PCORI To Solicit More Head-To-Head Comparative Studies

The Patient-Centered Outcomes Research Institute announces plans to encourage the submission of more proposals for head-to-head clinical comparative effectiveness studies. Among the research topics the institute will encourage are the Institute of Medicine’s top 100 priorities and recommendations from America’s Health Insurance Plans.

BIO Critical Of PCORI’s Timing, Lack Of Specificity In National Priorities And Research Agenda

Biotechnology Industry Organization calls for research emphasis on health care systems and delivery of health care during a stakeholder feedback session hosted by the Patient-Centered Outcomes Research Institute.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS055889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel